☆ 4.7 Article

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology

CLINICAL MICROBIOLOGY AND INFECTION (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Dermatology

Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study

Philipp Koehler et al.

Summary: Through simulation experiments, it was found that there is extensive aerosol generation, droplet spread, and surface contamination during bronchoscopy. By repurposing covers for ultrasound transducers or endoscopic cameras to seal the tube opening during bronchoscopy in mechanically ventilated patients, exposure of health-care workers and surface contamination can be efficiently reduced.

MYCOSES (2021)

添加到收藏夹

Article Dermatology

Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia

Gonzalo Segrelles-Calvo et al.

Summary: As the COVID-19 pandemic continues to spread globally, the risk of invasive fungal infections as a coinfection poses a significant threat to severely ill patients. Larger cohort studies are necessary to investigate the impact of COVID-19 immunosuppressive therapy on the development of aspergillosis.

MYCOSES (2021)

添加到收藏夹

Review Dermatology

Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

Marina Machado et al.

Summary: COVID-19-associated pulmonary aspergillosis is a serious and potentially life-threatening complication in severe COVID-19 patients, especially those receiving corticosteroids. Mortality rate in reviewed cases is high at 56.3%.

MYCOSES (2021)

添加到收藏夹

Article Dermatology

COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series

Eelco F. J. Meijer et al.

Summary: CAPA has emerged as an invasive fungal disease affecting previously immunocompetent, mechanically ventilated ICU patients with high mortality. This study found a significant decrease in the number of COVID-19 patients needing mechanical ventilation in the ICU during the second wave, but a slightly higher percentage were diagnosed with CAPA. The use of dexamethasone did not show significant impact on CAPA incidence or mortality rates.

MYCOSES (2021)

添加到收藏夹

Review Dermatology

Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches

Jeffrey D. Jenks et al.

Summary: This review focuses on the epidemiology, definitions, diagnostic tests, clinical presentation, and imaging findings of invasive aspergillosis (IA) in critically ill patients in the intensive care unit, providing direction for further research.

MYCOSES (2021)

添加到收藏夹

Article Critical Care Medicine

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

Lore Vanderbeke et al.

Summary: IAPA is a common and significant complication in critically ill influenza patients, with high mortality despite timely antifungal therapy. Prophylaxis with intravenous posaconazole did not significantly reduce the incidence of IAPA compared to standard-of-care. Alternative management strategies are needed due to the high mortality associated with early IAPA and the potential benefits of prophylaxis in some patients after 48 hours.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Letter Critical Care Medicine

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry

Juergen Prattes et al.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Letter Critical Care Medicine

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Juergen Prattes et al.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Article Mycology

Aspergillus fumigatus and aspergillosis: From basics to clinics

A. Arastehfar et al.

Summary: The airborne fungus Aspergillus fumigatus poses a serious health threat by causing invasive infections in humans, with frontline azole therapeutics being limited by the emergence of resistant isolates. The search for novel antifungal drugs to combat emerging resistance is ongoing, while advancements in genetic engineering and whole-genome sequencing are being explored to understand and address challenges caused by A. fumigatus.

STUDIES IN MYCOLOGY (2021)

添加到收藏夹

Article Immunology

COVID-19-Associated Pulmonary Aspergillosis, March-August 2020

Jon Salmanton-Garcia et al.

Summary: This study found that most patients with coronavirus disease-associated pulmonary aspergillosis (CAPA) are diagnosed shortly after admission, with the majority being treated in the ICU. Azole-resistant strains of Aspergillus fumigatus were common in patients, and voriconazole was the main treatment choice. The overall mortality rate was approximately 52.2%, with about one third of deaths attributed to CAPA.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Aspergillosis Complicating Severe Coronavirus Disease

Kieren A. Marr et al.

Summary: The syndromes of pulmonary aspergillosis complicating severe viral infections are distinct from classic invasive aspergillosis, which is recognized most frequently in persons with neutropenia and in other immunocompromised persons.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Critical Care Medicine

COVID-19-associated Pulmonary Aspergillosis

Andreas L. E. van Arkel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

添加到收藏夹

Letter Critical Care Medicine

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

Alexandre Alanio et al.

LANCET RESPIRATORY MEDICINE (2020)

添加到收藏夹

Article Dermatology

COVID-19 associated pulmonary aspergillosis

Philipp Koehler et al.

MYCOSES (2020)

添加到收藏夹

Letter Infectious Diseases

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia

T. Lahmer et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

添加到收藏夹

Review Critical Care Medicine

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

Paul E. Verweij et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Article Dermatology

COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan

Nosheen Nasir et al.

MYCOSES (2020)

添加到收藏夹

Review Infectious Diseases

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Philipp Koehler et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Review Infectious Diseases

The human lung and Aspergillus: You are what you breathe in?

Malcolm Richardson et al.

MEDICAL MYCOLOGY (2019)

添加到收藏夹

Article Dermatology

FungiScope™ - Global Emerging Fungal Infection Registry

Danila Seidel et al.

MYCOSES (2017)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.